The FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma (NHL). The decision throws a ...
Regeneron's CD20xCD3 bispecific antibody for non-Hodgin lymphoma (NHL) has been approved in Europe, five months after it was turned down by the FDA in the US. Ordspono (odronextamab) has been cleared ...
Design and Optimization of Heterogeneous Coded Distributed Computing With Nonuniform File Popularity
Abstract: This paper studies MapReduce-based heterogeneous coded distributed computing (CDC) where, besides different computing capabilities at workers, input files to be accessed by computing jobs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results